Arne Astrup. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Anti-Obesity Agents/adverse effectsAnti-Obesity Agents/therapeutic useBenzazepines/adverse effectsBenzazepines/therapeutic useContraindicationsCyclobutanesDrug Approval/legislation & jurisprudenceFenfluramine/adverse effectsHumansObesity/drug therapyOverweight/drug therapySerotonin 5-HT2 Receptor AgonistsSerotonin Receptor Agonists/therapeutic useUnited StatesUnited States Food and Drug AdministrationWeight Loss/drug effects
Substances: See more » Anti-Obesity AgentsBenzazepinesCyclobutanesSerotonin 5-HT2 Receptor AgonistsSerotonin Receptor AgonistsFenfluraminelorcaserinsibutramine
Year: 2010 PMID: 20647205 DOI: 10.1056/NEJMe1004076
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245